Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
UTHR
Stock Latest News
The Fly
United Therapeutics price target lowered to $330 from $350 at JPMorgan
17h ago
UTHR
Premium
Company Announcements
United Therapeutics’ Inhaled Treprostinil Study: A Potential Game-Changer for IPF Treatment
8d ago
UTHR
Premium
Company Announcements
United Therapeutics’ Promising Study on Inhaled Treprostinil for Pulmonary Fibrosis
8d ago
UTHR
Premium
The Fly
United Therapeutics price target lowered to $385 from $410 at UBS
9d ago
UTHR
Premium
The Fly
Liquidia price target lowered to $40 from $45 at BTIG
12d ago
LQDA
UTHR
Premium
Company Announcements
United Therapeutics Shareholders Approve Key Resolutions
12d ago
8K
UTHR
Premium
Company Announcements
United Therapeutics’ Ralinepag Study: A Potential Game-Changer in PAH Treatment
12d ago
UTHR
Premium
Ratings
United Therapeutics: Pioneering Organ Manufacturing and Strategic Growth with miroliverELAP
13d ago
UTHR
Premium
Company Announcements
United Therapeutics’ Ralinepag Study: A Potential Game-Changer for PAH Treatment
14d ago
UTHR
Premium
The Fly
United Therapeutics, Intermountain treat first patient with miroliverELAP
15d ago
UTHR
Premium
The Fly
United Therapeutics concludes enrollment in ADVANCE OUTCOMES study
15d ago
UTHR
Premium
Ratings
Buy Recommendation for United Therapeutics Based on Strong Market Position and Growth Potential
26d ago
UTHR
Premium
Ratings
United Therapeutics: Strong Market Position and Growth Potential Amidst Emerging Competition
28d ago
UTHR
Premium
The Fly
United Therapeutics price target lowered to $315 from $321 at BofA
28d ago
INSM
UTHR
Premium
The Fly
Morning Movers: Insmed jumps, United Therapeutics falls after TPIP study results
29d ago
ASO
BRO
Premium
The Fly
United Therapeutics falls after Insmed’s TPIP meets endpoints in study
29d ago
INSM
UTHR
Premium
The Fly
Liquidia price target raised to $32 from $25 at Needham
1M ago
LQDA
UTHR
Premium
The Fly
Liquidia schedules first commercial shipment of YUTREPIA
1M ago
LQDA
UTHR
Premium
The Fly
United Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
UTHR
Premium
Ratings
Maintaining Market Position: United Therapeutics’ Tyvaso DPI Amidst Competition and Future Growth Prospects
1M ago
UTHR
Premium
The Fly
Liquidia price target raised to $23 from $20 at Wells Fargo
1M ago
LQDA
UTHR
Premium
Ratings
Hold Rating for United Therapeutics Amid Competitive Pressures from LQDA’s Yutrepia
1M ago
UTHR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
